Latest news and press releases about IRIDEX Corporation (IRIX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment.
Price
| Price | $0.61 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.90 |
| EV / EBITDA | -6.71 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -78.94% |
| Return on Invested Capital | -19.53% |
| Return on Assets | -13.01% |
| Gross Margin | 36.23% |
| Operating Margin | -5.39% |
| Net Margin | -6.88% |
Related companies: ADGM · ALUR · ASBP · COCH · HOTH · IINN · NVNO
Explore sector: Healthcare · Medical - Devices
More sections of IRIX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks